DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning

The SARS-CoV-2 pandemic has demonstrated the need to create highly effective antivirals and vaccines against various RNA viruses, including SARS coronaviruses. This paper provides a short review of innovative strategies in the development of antivirals and vaccines against SARS coronaviruses, with a...

Full description

Bibliographic Details
Main Authors: Volodymyr V. Oberemok, Oksana A. Andreeva, Edie E. Alieva
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/2/1553
_version_ 1797441228739969024
author Volodymyr V. Oberemok
Oksana A. Andreeva
Edie E. Alieva
author_facet Volodymyr V. Oberemok
Oksana A. Andreeva
Edie E. Alieva
author_sort Volodymyr V. Oberemok
collection DOAJ
description The SARS-CoV-2 pandemic has demonstrated the need to create highly effective antivirals and vaccines against various RNA viruses, including SARS coronaviruses. This paper provides a short review of innovative strategies in the development of antivirals and vaccines against SARS coronaviruses, with a focus on antisense antivirals, oligonucleotide adjuvants in vaccines, and oligonucleotide vaccines. Well-developed viral genomic databases create new opportunities for the development of innovative vaccines and antivirals using a post-genomic platform. The most effective vaccines against SARS coronaviruses are those able to form highly effective memory cells for both humoral and cellular immunity. The most effective antivirals need to efficiently stop viral replication without side effects. Oligonucleotide antivirals and vaccines can resist the rapidly changing genomic sequences of SARS coronaviruses using conserved regions of their genomes to generate a long-term immune response. Oligonucleotides have been used as excellent adjuvants for decades, and increasing data show that oligonucleotides could serve as antisense antivirals and antigens in vaccine formulations, becoming a prospective tool for immune system tuning.
first_indexed 2024-03-09T12:20:00Z
format Article
id doaj.art-919b01cdcc9a4af59fde79d9afff0fba
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T12:20:00Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-919b01cdcc9a4af59fde79d9afff0fba2023-11-30T22:42:12ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-01-01242155310.3390/ijms24021553DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System TuningVolodymyr V. Oberemok0Oksana A. Andreeva1Edie E. Alieva2Department of Molecular Genetics and Biotechnologies, Institute of Biochemical Technologies, Ecology and Pharmacy, V.I. Vernadsky Crimean Federal University, 295007 Simferopol, CrimeaDepartment of Molecular Genetics and Biotechnologies, Institute of Biochemical Technologies, Ecology and Pharmacy, V.I. Vernadsky Crimean Federal University, 295007 Simferopol, CrimeaDepartment of Molecular Genetics and Biotechnologies, Institute of Biochemical Technologies, Ecology and Pharmacy, V.I. Vernadsky Crimean Federal University, 295007 Simferopol, CrimeaThe SARS-CoV-2 pandemic has demonstrated the need to create highly effective antivirals and vaccines against various RNA viruses, including SARS coronaviruses. This paper provides a short review of innovative strategies in the development of antivirals and vaccines against SARS coronaviruses, with a focus on antisense antivirals, oligonucleotide adjuvants in vaccines, and oligonucleotide vaccines. Well-developed viral genomic databases create new opportunities for the development of innovative vaccines and antivirals using a post-genomic platform. The most effective vaccines against SARS coronaviruses are those able to form highly effective memory cells for both humoral and cellular immunity. The most effective antivirals need to efficiently stop viral replication without side effects. Oligonucleotide antivirals and vaccines can resist the rapidly changing genomic sequences of SARS coronaviruses using conserved regions of their genomes to generate a long-term immune response. Oligonucleotides have been used as excellent adjuvants for decades, and increasing data show that oligonucleotides could serve as antisense antivirals and antigens in vaccine formulations, becoming a prospective tool for immune system tuning.https://www.mdpi.com/1422-0067/24/2/1553antisense oligonucleotidesantisense antiviralsoligonucleotide adjuvantsoligonucleotide vaccinesSARS coronavirusesinnate immunity
spellingShingle Volodymyr V. Oberemok
Oksana A. Andreeva
Edie E. Alieva
DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning
International Journal of Molecular Sciences
antisense oligonucleotides
antisense antivirals
oligonucleotide adjuvants
oligonucleotide vaccines
SARS coronaviruses
innate immunity
title DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning
title_full DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning
title_fullStr DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning
title_full_unstemmed DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning
title_short DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning
title_sort dna oligonucleotides as antivirals and vaccine constituents against sars coronaviruses a prospective tool for immune system tuning
topic antisense oligonucleotides
antisense antivirals
oligonucleotide adjuvants
oligonucleotide vaccines
SARS coronaviruses
innate immunity
url https://www.mdpi.com/1422-0067/24/2/1553
work_keys_str_mv AT volodymyrvoberemok dnaoligonucleotidesasantiviralsandvaccineconstituentsagainstsarscoronavirusesaprospectivetoolforimmunesystemtuning
AT oksanaaandreeva dnaoligonucleotidesasantiviralsandvaccineconstituentsagainstsarscoronavirusesaprospectivetoolforimmunesystemtuning
AT edieealieva dnaoligonucleotidesasantiviralsandvaccineconstituentsagainstsarscoronavirusesaprospectivetoolforimmunesystemtuning